Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Helen McShane: Fighting TB – South Africa’s ‘insidious epidemic’

In this section

South Africa stands at the centre of a global TB epidemic devastating the health of millions and their communities. Oxford University is working with South African researchers, health workers and community volunteers in the hunt for an urgently-needed new vaccine.

Read more about Research on TB conducted at the University of Oxford.

Helen McShane

Development of a new vaccine against Tuberculosis

Professor Helen McShane has been working on a new TB vaccine for 10 years. There are about 9 million new cases and 1.7 million deaths every year from tuberculosis. She developed MVA85A, a vaccine with the aim to boost the cellular immune response induced by BCG. Developing countries are especially in need of a new vaccine since HIV and TB epidemics overlap and show a devastating synergy.

Outreach podcasts

Understanding great research doesn't have to be confusing. In this series of podcasts, our researchers explain what they get up to for a general audience.